Peran curcumin pada non-alcoholic fatty liver disease atau fatty liver (NAFLD) telah diteliti, oleh karena curcumin memiliki efek antioksidan dan antiinflamasi. Curcumin adalah ekstrak dari kunyit, yang merupakan salah satu obat tradisional dengan potensi protektif terhadap organ hati. Sementara, NAFLD diduga disebabkan oleh stres oksidatif pada hepatosit.[1,2,4,5]
Prevalensi non-alcoholic fatty liver disease (NAFLD) atau perlemakan hati mencapai 25% di seluruh dunia. Kondisi ini seringkali asimtomatik, di mana gejala ringan yang dapat dikeluhkan adalah nyeri abdomen kanan atas dan fatigue.[3,4]
Hingga saat ini, patofisiologi NAFLD masih belum diketahui dengan pasti. Studi terdahulu melaporkan adanya steatohepatitis dan fibrosis dari hasil biopsi hati, yang disebabkan oleh stres oksidatif pada hepatosit. Dugaan sementara, NAFLD terjadi akibat hasil interaksi antara genetik, lingkungan, dan stres metabolik.[4]
(Konten ini khusus untuk dokter. Registrasi untuk baca selengkapnya)
Referensi
1. Alm-Eldeen AA, Mona MH, et al. Synergistic effect of black tea and curcumin in improving the hepatotoxicity induced by aflatoxin B1 in rats. Toxicol Ind Health. 2015;31(12):1269-80.
2. Leclercq IA, Farrell GC, et al. Curcumin inhibits NF-kappaB activation and reduces the severity of experimental steatohepatitis in mice. J Hepatol. 2004;41(6):926-34.
3. Mayo Clinic. Nonalcoholic fatty liver disease Arizona: Mayo Clinic; 2025. https://www.mayoclinic.org/diseases-conditions/nonalcoholic-fatty-liver-disease/symptoms-causes/syc-20354567.
4. Shi T, Wu L, Ma W, et al. Nonalcoholic Fatty Liver Disease: Pathogenesis and Treatment in Traditional Chinese Medicine and Western Medicine. Evidence-Based Complementary and Alternative Medicine. 2020;2020:8749564.
5. Lee DE, Lee SJ, et al. Curcumin Ameliorates Nonalcoholic Fatty Liver Disease through Inhibition of O-GlcNAcylation. Nutrients. 2019;11(11).
6. Rahmani S, Asgary S, et al. Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo- controlled Trial. Phytotherapy Research. 2016;30(9):1540-8.
7. Panahi Y, Kianpour P, et al. Efficacy of phospholipidated curcumin in nonalcoholic fatty liver disease: a clinical study. Journal of Asian Natural Products Research. 2018;2018(2):1-8.
8. Mansour-Ghanaei F, Pourmasoumi M, et al. Efficacy of curcumin/turmeric on liver enzymes in patients with non-alcoholic fatty liver disease: A systematic review of randomized controlled trials. Integr Med Res. 2019;8(1):57-6.
9. Malik A, Malik M. Effects of curcumin in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis. Can Liver J. 2024 May 8;7(2):299-315. doi: 10.3138/canlivj-2023-0022.
10. Luber RP, Rentsch C, et al. Turmeric Induced Liver Injury: A Report of Two Cases. Case Reports in Hepatology. 2019;2019:6741213.
11. Saadati S, Hatami B, et al. The effects of curcumin supplementation on liver enzymes, lipid profile, glucose homeostasis, and hepatic steatosis and fibrosis in patients with non-alcoholic fatty liver disease. European Journal of Clinical Nutrition. 2019;441-449.